Genetic influence on the structural variations of the abnormal prion protein

被引:249
作者
Parchi, P
Zou, WQ
Wang, W
Brown, P
Capellari, S
Ghetti, B
Kopp, N
Schulz-Schaeffer, WJ
Kretzschmar, HA
Head, MW
Ironside, JW
Gambetti, P [1 ]
Chen, SG
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] NINDS, Cent Nervous Syst Studies Lab, Bethesda, MD 20892 USA
[3] Indiana Univ, Med Ctr, Dept Pathol, Indianapolis, IN 46202 USA
[4] Hop Neurol & Neurochirurg P Wertheimer, F-69003 Lyon, France
[5] Univ Gottingen, Inst Neuropathol, D-37075 Gottingen, Germany
[6] Western Gen Hosp, Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
10.1073/pnas.97.18.10168
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prion diseases are characterized by the presence of the abnormal prion protein PrPSc, which is believed to be generated by the conversion of the alpha-helical structure that predominates in the normal PrP isoform into a beta-sheet structure resistant to proteinase K (PK). In human prion diseases, two major types of PrPSc, type 1 and 2, can be distinguished based on the difference in electrophoretic migration of the PK-resistant core fragment. In this study, protein sequencing was used to identify the PK cleavage sites of PrPSc in 36 cases of prion diseases. We demonstrated two primary cleavage sites at residue 82 and residue 97 for type 1 and type 2 PrPSc, respectively, and numerous secondary cleavages distributed along the region spanning residues 74-102. Accordingly, we identify three regions in PrPSc: one N-terminal (residues 23-73) that is invariably PK-sensitive, one C-terminal (residues 103-231) that is invariably PK-resistant, and a third variable region (residues 74-102) where the site of the PK cleavage, likely reflecting the extent of the beta-sheet structure, varies mostly as a function of the PrP genotype at codon 129.
引用
收藏
页码:10168 / 10172
页数:5
相关论文
共 30 条
[1]   BIOCHEMICAL AND PHYSICAL-PROPERTIES OF THE PRION PROTEIN FROM 2 STRAINS OF THE TRANSMISSIBLE MINK ENCEPHALOPATHY AGENT [J].
BESSEN, RA ;
MARSH, RF .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2096-2101
[2]   ISOLATION AND STRUCTURAL STUDIES OF THE INTACT SCRAPIE AGENT PROTEIN [J].
BOLTON, DC ;
BENDHEIM, PE ;
MARMORSTEIN, AD ;
POTEMPSKA, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1987, 258 (02) :579-590
[3]   Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [J].
Bruce, ME ;
Will, RG ;
Ironside, JW ;
McConnell, I ;
Drummond, D ;
Suttie, A ;
McCardle, L ;
Chree, A ;
Hope, J ;
Birkett, C ;
Cousens, S ;
Fraser, H ;
Bostock, CJ .
NATURE, 1997, 389 (6650) :498-501
[4]   THE DISEASE CHARACTERISTICS OF DIFFERENT STRAINS OF SCRAPIE IN SINC CONGENIC MOUSE LINES - IMPLICATIONS FOR THE NATURE OF THE AGENT AND HOST CONTROL OF PATHOGENESIS [J].
BRUCE, ME ;
MCCONNELL, I ;
FRASER, H ;
DICKINSON, AG .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :595-603
[5]   Strain-dependent differences in β-sheet conformations of abnormal prion protein [J].
Caughey, B ;
Raymond, GJ ;
Bessen, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32230-32235
[6]   Allelic origin of the abnormal prion protein isoform in familial prion diseases [J].
Chen, SG ;
Parchi, P ;
Brown, P ;
Capellari, S ;
Zou, WQ ;
Cochran, EJ ;
VnencakJones, CL ;
Julien, J ;
Vital, C ;
Mikol, J ;
Lugaresi, E ;
AutilioGambetti, L ;
Gambetti, P .
NATURE MEDICINE, 1997, 3 (09) :1009-1015
[7]   TRUNCATED FORMS OF THE HUMAN PRION PROTEIN IN NORMAL BRAIN AND IN PRION DISEASES [J].
CHEN, SG ;
TEPLOW, DB ;
PARCHI, P ;
TELLER, JK ;
GAMBETTI, P ;
AUTILIOGAMBETTI, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19173-19180
[8]   Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD [J].
Collinge, J ;
Sidle, KCL ;
Meads, J ;
Ironside, J ;
Hill, AF .
NATURE, 1996, 383 (6602) :685-690
[9]   GENETIC PREDISPOSITION TO IATROGENIC CREUTZFELDT-JAKOB DISEASE [J].
COLLINGE, J ;
PALMER, MS ;
DRYDEN, AJ .
LANCET, 1991, 337 (8755) :1441-1442
[10]   Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease [J].
Gabizon, R ;
Telling, G ;
Meiner, Z ;
Halimi, H ;
Kahana, I ;
Prusiner, SB .
NATURE MEDICINE, 1996, 2 (01) :59-64